Stocks edged back from record highs on Wednesday as Wall Street bumped up against underwhelming economic data, while oil continued to rise and the dollar weakened ahead of comments from the US Federal Reserve.
The US dollar has lost some of its safe-haven luster as traders turn to riskier assets, including some funded in other currencies, following positive news about a COVID-19 vaccine and a seemingly normalizing US transition of power.
Former Fed Chair Janet Yellen’s reported nomination to Treasury Secretary has emboldened those risk bets and further weighed on the dollar.
“From here, the Fed will prove a mere auxiliary to maximize fiscal impact by ensuring cheap funding,” said John Hardy, head of FX strategy at Saxo Bank.
“The long-term implications of the Yellen nomination are distinctly dollar negative.”
Minutes from the most recent Fed meeting are due later in the session.
The dollar index fell 0.085 percent, with the euro up 0.14 percent to $1.1905.
The Japanese yen strengthened 0.06 percent versus the greenback to 104.37 per dollar, while sterling was last trading at $1.3374, up 0.13 percent on the day.
US President-elect Biden to unveil economic team next week
On Wall Street, a surprise jump in weekly jobless claims added to signs the recovery in the labor market was stalling as the United States battled a new wave of COVID-19 infections.
MSCI’s broadest gauge of world stocks was last trading down 0.13 percent, after renewed demand for shares earlier pushed it to a record high of 622.12.
The rally in global stocks is set to continue for at least six months, a Reuters poll forecast on Wednesday.
But on Wednesday the Dow Jones Industrial Average fell 196.81 points, or 0.66 percent, to 29,849.43, the S&P 500 lost 12.19 points, or 0.34 percent, to 3,623.22 and the Nasdaq Composite added 8.70 points, or 0.07 percent, to 12,045.49.
“The question is, who wins the battle: the vaccines, or the rising cases in the short term?” said Christopher C. Grisanti, chief equity strategist at MAI Capital Management.
Optimism around vaccine developments and expectations of a recovery in corporate confidence and profitability should also push European stocks to near record highs next year, a separate Reuters survey found.
On Wednesday the pan-European STOXX 600 index lost 0.06 percent while Japan’s Nikkei rose 0.50 percent after touching a 29-year high.
MSCI’s broadest index of Asia-Pacific shares outside Japan closed 0.57 percent lower, with Chinese shares capped by worries about rising debt defaults.
The job market data weighed on Treasury yields.
Benchmark 10-year notes last rose 5/32 in price to yield 0.8668 percent, from 0.882 percent late on Tuesday.
Oil continued to rise beyond pre-pandemic levels on bets for a speedy recovery in energy demand.
“Crude oil prices are trading at their highest levels since early March, supported by positive market sentiment as a result of vaccine news and strong oil demand in Asia,” said UBS oil analyst Giovanni Staunovo.
“We maintain our bullish outlook for next year and target rent to hit $60 per barrel at the end of 2021,” he added.
US financial markets will be closed on Thursday for the Thanksgiving holiday.
Oil prices extend gains, at highest levels since early March, on coronavirus vaccineOil prices climbed for a fourth straight session on Wednesday, shrugging off a report showing US crude inventories rose more than expected and ... Coronavirus
Global oil markets well supplied, says IEA after attack on Saudi oil facilityThe International Energy Agency (IEA) said on Tuesday that global oil markets remained well supplied after an attack on Saudi Arabia’s oil facility a ... Energy
Oil prices hit highest since March toward $47 on vaccine trials, Biden transitionOil hit its highest since March on Tuesday, rising toward $47 a barrel, as a third promising coronavirus vaccine spurred demand recovery hopes and US ... Energy
Saudi Arabia will be among first countries to receive coronavirus vaccine: CabinetSaudi Arabia will be among the first countries to receive a vaccine against the coronavirus, the cabinet said on Tuesday, according to state news ... Coronavirus
Coronavirus: EU to sign deal for up to 160 million doses of Moderna COVID-19 vaccineThe European Union will sign a contract for up to 160 million doses of US drugmaker Moderna’s experimental coronavirus vaccine, Ursula von der Leyen, ... Coronavirus
Russia: Our coronavirus vaccine 95 pct effective, costs less than $10 per dose abroadRussia said new results showed its locally developed coronavirus vaccine, Sputnik V, had over 95 percent efficacy and promised it would cost less than ... Coronavirus